{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:28:39Z","timestamp":1792506519069,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eclinm.2026.103992","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:40:15Z","timestamp":1779990015000},"page":"103992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Weight maintenance after discontinuation of GLP-1 therapies"],"prefix":"10.1016","volume":"96","author":[{"given":"Areesha","family":"Moiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-0088","authenticated-orcid":false,"given":"Kristian B.","family":"Filion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Kn\u00e4uper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-2920","authenticated-orcid":false,"given":"Anne-Sophie","family":"Brazeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Zolotarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-0661","authenticated-orcid":false,"given":"Mark J.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.103992_bib1","series-title":"Obesity and GLP-1 drugs: a claims-based analysis. White paper","year":"2025"},{"key":"10.1016\/j.eclinm.2026.103992_bib2","series-title":"Medication treatments for diabetes and obesity in Canada, 2019\u20132023","year":"2024"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103992_bib3","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.37765\/ajmc.2025.89778","article-title":"Trends in glucagon-like peptide 1 receptor agonist prescribing patterns","volume":"31","author":"Ukhanova","year":"2025","journal-title":"Am J Manag Care"},{"issue":"10455","key":"10.1016\/j.eclinm.2026.103992_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(24)01356-4","article-title":"International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches","volume":"404","author":"Dellgren","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/ANNALS-24-01590","article-title":"Efficacy and safety of glucagon-like Peptide-1 receptor agonists for weight loss among adults without diabetes : a systematic review of randomized controlled trials","volume":"178","author":"Moiz","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103992_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"10.1016\/j.eclinm.2026.103992_bib8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.103992_bib10","article-title":"World Health Organization guideline on the use and indications of glucagon-like Peptide-1 therapies for the treatment of obesity in adults","author":"Celletti","year":"2025","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103992_bib11","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41591-025-03765-w","article-title":"Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO)","volume":"31","author":"McGowan","year":"2025","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"10.1016\/j.eclinm.2026.103992_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/dom.16364","article-title":"Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies","volume":"27 Suppl 2","author":"Thomsen","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eclinm.2026.103992_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2025.6112","article-title":"Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity: a post hoc analysis of the SURMOUNT-4 trial","author":"Horn","year":"2026","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103680","article-title":"Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis","volume":"90","author":"Tzang","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103992_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.13172","article-title":"GLP-1 receptor agonist discontinuation among patients with obesity and\/or type 2 diabetes","volume":"7","author":"Do","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103992_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/oby.24315","article-title":"Titration and discontinuation of semaglutide for weight management in commercially insured US adults","volume":"33","author":"Xu","year":"2025","journal-title":"Obesity"},{"issue":"9248","key":"10.1016\/j.eclinm.2026.103992_bib18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103992_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eclinm.2026.103992_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101436","article-title":"The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy","volume":"49","author":"le Roux","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103992_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jech-2019-213419","article-title":"Weight cycling is associated with adverse cardiometabolic markers in a cross-sectional representative US sample","volume":"74","author":"Kakinami","year":"2020","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.eclinm.2026.103992_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fendo.2019.00728","article-title":"Body-weight fluctuation was associated with increased risk for cardiovascular disease, all-cause and cardiovascular mortality: a systematic review and meta-analysis","volume":"10","author":"Zou","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eclinm.2026.103992_bib24","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf348","article-title":"Weight trajectory impacts risk for ten distinct cardiometabolic diseases","author":"Swartz","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/biores.2017.0044","article-title":"Fatness and fluctuating body weight: effect on central vasculature","volume":"7","author":"Zeigler","year":"2018","journal-title":"Biores Open Access"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103992_bib26","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.2337\/dc14-0018","article-title":"Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program","volume":"37","author":"Delahanty","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2026.103992_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103992_bib28","first-page":"846","article-title":"Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lee","year":"2025","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.eclinm.2026.103992_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.eclinm.2026.103992_bib30","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1056\/NEJMoa2505928","article-title":"Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes","volume":"393","author":"Nicholls","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103992_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103992_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"10516","key":"10.1016\/j.eclinm.2026.103992_bib33","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","article-title":"Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial","volume":"406","author":"Deanfield","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.103992_bib34","article-title":"Temporal and subgroup disparities in mediation effects on cardiovascular outcomes with liraglutide and semaglutide: a post-hoc analysis of LEADER and SUSTAIN-6 trials","author":"Peng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.eclinm.2026.103992_bib35","article-title":"GLP-1 receptor agonists and blood pressure: a state-of-the-art review of mechanisms, evidence, and clinical implications","author":"Moiz","year":"2025","journal-title":"Am J Hypertens"},{"issue":"10157","key":"10.1016\/j.eclinm.2026.103992_bib36","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2025-002150","article-title":"Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation","volume":"5","author":"Xie","year":"2026","journal-title":"BMJ Med"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103992_bib38","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.amjmed.2025.01.021","article-title":"Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation","volume":"138","author":"Moiz","year":"2025","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103992_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib40","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/ijo.2010.184","article-title":"Adaptive thermogenesis in humans","volume":"34 Suppl 1","author":"Rosenbaum","year":"2010","journal-title":"Int J Obes"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103992_bib41","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/oby.21538","article-title":"Persistent metabolic adaptation 6 years after \u201cThe Biggest Loser\u201d competition","volume":"24","author":"Fothergill","year":"2016","journal-title":"Obesity"},{"issue":"17","key":"10.1016\/j.eclinm.2026.103992_bib42","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/CS20120223","article-title":"The defence of body weight: a physiological basis for weight regain after weight loss","volume":"124","author":"Sumithran","year":"2013","journal-title":"Clin Sci"},{"key":"10.1016\/j.eclinm.2026.103992_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnut.2014.00007","article-title":"Neural responses to visual food cues according to weight status: a systematic review of functional magnetic resonance imaging studies","volume":"1","author":"Pursey","year":"2014","journal-title":"Front Nutr"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103992_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/nu15051173","article-title":"The association of emotional eating with overweight\/obesity, depression, anxiety\/stress, and dietary patterns: a review of the current clinical evidence","volume":"15","author":"Dakanalis","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuron.2011.02.016","article-title":"Reward mechanisms in obesity: new insights and future directions","volume":"69","author":"Kenny","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.eclinm.2026.103992_bib47","series-title":"Psychological issues associated with obesity","author":"Segal","year":"2025"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103992_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/sah0000088","article-title":"Weight stigma facilitates unhealthy eating and weight gain via fear of fat","volume":"3","author":"Wellman","year":"2018","journal-title":"Stigma Health"},{"issue":"16","key":"10.1016\/j.eclinm.2026.103992_bib49","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.cell.2025.06.010","article-title":"Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy","volume":"188","author":"Johansen","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64847-2","article-title":"Social and environmental stressors of cardiometabolic health","volume":"14","author":"Bartoskova Polcrova","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103992_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108870","article-title":"Environmental pollution and the risk of developing metabolic disorders: obesity and diabetes","volume":"24","author":"Khalil","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103992_bib52","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/oby.21454","article-title":"The impact of continued intervention on weight: five-year results from the weight loss maintenance trial","volume":"24","author":"Coughlin","year":"2016","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/oby.20662","article-title":"Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study","volume":"22","author":"Look","year":"2014","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/osp4.3","article-title":"Body weight dynamics following intentional weight loss and physical performance: the look AHEAD movement and memory study","volume":"1","author":"Beavers","year":"2015","journal-title":"Obes Sci Pract"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amepre.2013.08.019","article-title":"Weight-loss maintenance for 10 years in the National weight Control Registry","volume":"46","author":"Thomas","year":"2014","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1743-7075-11-53","article-title":"A high-protein diet for reducing body fat: mechanisms and possible caveats","volume":"11","author":"Pesta","year":"2014","journal-title":"Nutr Metab"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103992_bib57","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/oby.20154","article-title":"High protein intake stimulates postprandial GLP1 and PYY release","volume":"21","author":"van der Klaauw","year":"2013","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103992_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jn\/nxz281","article-title":"High compared with moderate protein intake reduces adaptive thermogenesis and induces a negative energy balance during long-term weight-loss maintenance in participants with prediabetes in the Postobese state: a PREVIEW Study","volume":"150","author":"Drummen","year":"2020","journal-title":"J Nutr"},{"issue":"22","key":"10.1016\/j.eclinm.2026.103992_bib59","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1007137","article-title":"Diets with high or low protein content and glycemic index for weight-loss maintenance","volume":"363","author":"Larsen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib60","article-title":"A high-protein, low glycemic index diet suppresses hunger but not weight regain after weight loss: results from a large, 3-Years randomized trial (PREVIEW)","volume":"8","author":"Zhu","year":"2021","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mcna.2017.08.012","article-title":"Maintenance of lost weight and long-term management of obesity","volume":"102","author":"Hall","year":"2018","journal-title":"Med Clin North Am"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib62","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jama.2014.10397","article-title":"Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis","volume":"312","author":"Johnston","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103992_bib63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa0708681","article-title":"Weight loss with a low-carbohydrate, mediterranean, or low-fat diet","volume":"359","author":"Shai","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clnu.2025.08.009","article-title":"Diet strategies for maintaining substantial therapeutic weight loss: 78-week mixed methods randomised trial","volume":"53","author":"Brosnahan","year":"2025","journal-title":"Clin Nutr"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103992_bib65","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The diabetes prevention program (DPP): description of lifestyle intervention","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2026.103992_bib66","series-title":"StatPearls","article-title":"The DASH diet: a guide to managing hypertension through nutrition","author":"Daley","year":"2026"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/nu17020358","article-title":"Effects of the mediterranean diet on the components of metabolic syndrome concerning the cardiometabolic risk","volume":"17","author":"Scaglione","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.eclinm.2026.103992_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.eclinm.2026.103992_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26 Suppl 4","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103992_bib70","article-title":"Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans","volume":"7","author":"Langer","year":"2026","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103992_bib71","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","volume":"18","author":"Gatto","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s40279-025-02386-0","article-title":"Physical fitness with exercise and GLP-1 receptor agonist treatment alone or combined after diet-induced weight loss: a secondary analysis of a randomized controlled trial in adults with obesity","author":"Jensen","year":"2026","journal-title":"Sports Med"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103992_bib73","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/dbi25-0003","article-title":"High-quality weight loss in obesity: importance of skeletal muscle","volume":"74","author":"Harper","year":"2025","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib74","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13679-016-0237-4","article-title":"Changes in energy expenditure with weight gain and weight loss in humans","volume":"5","author":"Muller","year":"2016","journal-title":"Curr Obes Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103992_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"key":"10.1016\/j.eclinm.2026.103992_bib76","article-title":"Resistance training as a key strategy for high-quality weight loss in men and women","volume":"16","author":"Lahav","year":"2025","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib77","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1249\/MSS.0000000000000605","article-title":"Resistance exercise training alters mitochondrial function in human skeletal muscle","volume":"47","author":"Porter","year":"2015","journal-title":"Med Sci Sports Exerc"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103992_bib78","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2505669","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes","volume":"393","author":"Rosenstock","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd12040158","article-title":"Narrative review of high-intensity interval training: positive impacts on cardiovascular health and disease prevention","volume":"12","author":"Ko","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"issue":"Suppl 4","key":"10.1016\/j.eclinm.2026.103992_bib80","article-title":"Effect of exercise training on psychological outcomes in adults with overweight or obesity: a systematic review and meta-analysis","volume":"22 Suppl 4","author":"Carraca","year":"2021","journal-title":"Obes Rev"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103992_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19084893","article-title":"Effects of different low-intensity exercise types on duration, energy expenditure and perceived exertion in Obese individuals","volume":"19","author":"Khanfir","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1 Suppl","key":"10.1016\/j.eclinm.2026.103992_bib82","doi-asserted-by":"crossref","first-page":"222S","DOI":"10.1093\/ajcn\/82.1.222S","article-title":"Long-term weight loss maintenance","volume":"82","author":"Wing","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12160-011-9279-8","article-title":"Attrition and adherence rates of sustained vs. intermittent exercise interventions","volume":"42","author":"Linke","year":"2011","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/PRBM.S113278","article-title":"Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives","volume":"10","author":"Castelnuovo","year":"2017","journal-title":"Psychol Res Behav Manag"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib85","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s12671-022-01951-2","article-title":"Effects of a mindfulness-based weight loss intervention on long-term psychological well-being among adults with obesity: secondary analyses from the supporting health by integrating nutrition and exercise (SHINE) trial","volume":"13","author":"Hooker","year":"2022","journal-title":"Mindfulness"},{"issue":"9702","key":"10.1016\/j.eclinm.2026.103992_bib86","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study","volume":"374","author":"Diabetes Prevention Program Research Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.103992_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1250683","article-title":"Dropout in cognitive behavioral treatment in adults living with overweight and obesity: a systematic review","volume":"11","author":"Neri","year":"2024","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7812\/TPP\/21.212","article-title":"Behavioral weight loss and maintenance: a 25-Year research program informing innovative programming","volume":"26","author":"Annesi","year":"2022","journal-title":"Perm J"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib89","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1039856219871882","article-title":"Evaluation of an online cognitive behavioural therapy weight loss programme as an adjunct to anti-obesity medications and lifestyle interventions","volume":"28","author":"Tham","year":"2020","journal-title":"Australas Psychiatry"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103992_bib90","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/oby.2007.368","article-title":"Consistent self-monitoring of weight: a key component of successful weight loss maintenance","volume":"15","author":"Butryn","year":"2007","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103992_bib91","article-title":"Can digital technologies be useful for weight loss in individuals with overweight or obesity? A systematic review","volume":"12","author":"Protano","year":"2024","journal-title":"Healthcare (Basel)"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12170-023-00717-2","article-title":"The efficacy of Mobile applications for weight loss","volume":"17","author":"Ufholz","year":"2023","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib93","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.29136","article-title":"Peer coaching to support weight management in primary care: a cluster randomized clinical trial","volume":"8","author":"Wittleder","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103992_bib94","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamainternmed.2025.1345","article-title":"Patient-delivered continuous care for weight loss maintenance: a randomized clinical trial","volume":"185","author":"Leahey","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/dom.70096","article-title":"Treat to target in weight management with semaglutide: real-world evidence from an eHealth clinic","author":"Seier","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103992_bib96","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/oby.24302","article-title":"Less frequent dosing of GLP-1 receptor agonists as a viable weight maintenance strategy","volume":"33","author":"Wu","year":"2025","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib97","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/dom.16229","article-title":"Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy","volume":"27","author":"Cengiz","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103992_bib98","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103992_bib99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-018-3525-0","article-title":"Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-Year outcomes after adjustable gastric banding","volume":"29","author":"O'Brien","year":"2019","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103992_bib100","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1007\/s00464-023-10390-6","article-title":"Endoscopic therapies for patients with obesity: a systematic review and meta-analysis","volume":"37","author":"Weitzner","year":"2023","journal-title":"Surg Endosc"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib101","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4253\/wjge.v7.i9.847","article-title":"Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration","volume":"7","author":"Kumar","year":"2015","journal-title":"World J Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103992_bib102","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2337\/dc24-1110","article-title":"Cost-effectiveness of the national diabetes prevention program: a real-world, 2-Year prospective study","volume":"48","author":"Kuo","year":"2025","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103992_bib103","first-page":"1029","article-title":"Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes","volume":"31","author":"Wu","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103992_bib104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMp2515668","article-title":"Generic liraglutide - overlooked but not forgotten","volume":"394","author":"Gondi","year":"2026","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103992_bib105","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.0905","article-title":"Fiscal impact of expanded medicare coverage for GLP-1 receptor agonists to treat obesity","volume":"6","author":"Hwang","year":"2025","journal-title":"JAMA Health Forum"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib106","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2504214","article-title":"Once-monthly maridebart cafraglutide for the treatment of obesity - a phase 2 trial","volume":"393","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103992_bib107","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamainternmed.2025.1133","article-title":"I am taking a GLP-1 weight-loss medication-what should I know?","volume":"185","author":"Mehrtash","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eclinm.2026.103992_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"EClinicalMedicine"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:30:08Z","timestamp":1791232208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026002403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":108,"alternative-id":["S2589537026002403"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103992","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight maintenance after discontinuation of GLP-1 therapies","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103991","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103992"}}